You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroenteropancreatic

Showing 1 - 25 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 30, 2023

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Gastroenteropancreatic Neuroendocrine Tumors Trial in Marseille ([68Ga]-DOTANOC PET/CT)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumors
  • [68Ga]-DOTANOC PET/CT
  • Marseille, France
    AP-HM
Oct 12, 2022

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Patients With Gastroenteropancreatic Neuroendocrine Tumors Trial in France (68-Ga-DOTANOC)

Completed
  • Patients With Gastroenteropancreatic Neuroendocrine Tumors
  • Angers, France
  • +4 more
Jan 6, 2022

Lutathera® in Somatostatin Receptor Positive

Recruiting
  • Somatostatin Receptor-positive GEP-NET
  • Lutathera
  • Seongnam Si, Gyeonggi Do, Korea, Republic of
  • +4 more
Jun 29, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Neuroendocrine Tumors Trial in Belgium (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))

Recruiting
  • Neuroendocrine Tumors
  • Liquid biopsies
  • Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
  • Bornem, Antwerp, Belgium
  • +7 more
Jun 1, 2022

Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

Active, not recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
    • El Palmar, Murcia, Spain
    • +15 more
    Feb 16, 2022

    Neuroendocrine Tumors Trial in Edegem, Sint-Niklaas, Nicosia (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))

    Recruiting
    • Neuroendocrine Tumors
    • Liquid biopsies
    • Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
    • Edegem, Antwerp, Belgium
    • +2 more
    Feb 24, 2022

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Aix-en-Provence, France
    • +6 more
    Mar 9, 2022

    Assay asBiomarker for Gastroenteropancreatic and Lung

    Completed
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Lung Neuroendocrine Neoplasm
    • NETest
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 3, 2021

    Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

    Not yet recruiting
    • Neuroendocrine Tumors,Gastroenteropancreatic
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 9, 2021

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
    • long-acting Octreotide.
    • (no location specified)
    May 22, 2023

    Neuroendocrine Tumor, Gastroenteropancreatic Trial in Milano (Surgery)

    Active, not recruiting
    • Neuroendocrine Tumor
    • Gastroenteropancreatic
    • Surgery
    • Milano, Italy
      San Raffaele Hospital IRCCS
    May 5, 2022

    Financial Toxicity and Patient-Reported Outcomes in GEP-NEN

    Recruiting
    • Neuroendocrine Tumors
      • Milan, Italy
        IRCCS Ospedale San Raffaele
      Apr 16, 2022

      Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

      Completed
      • Gastroenteropancreatic Neuroendocrine Tumor
      • Lanreotide autogel
      • Sichuan, Chengdu, China
      • +13 more
      Jan 16, 2023

      Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

      Not yet recruiting
      • Neuroendocrine Tumors
      • +6 more
      • Vancouver, British Columbia, Canada
        BC Cancer
      Aug 19, 2022

      Effectiveness and Outcomes Associated With Lutathera Treatment

      Active, not recruiting
      • Gastroenteropancreatic Neuroendocrine Tumor
      • Alessandria, Italy
      • +17 more
      May 4, 2022